Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial
Kaja E Kjørholt, Nina Paulshus Sundlisæter, Anna‐Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Hallvard Fremstad, C. Spada, Tor Magne Madland, Christian Høili, Gunnstein Bakland, Åse Stavland Lexberg, Inger Johanne Widding Hansen, Inger Myrnes Hansen, Hilde Haukeland, Maud-Kristine Aga Ljoså, Ellen Moholt, Till Uhlig, Tore K Kvien, Daniel H. Solomon, Désirée van der Heijde, Espen A. Haavardsholm, Siri Lillegraven
Topics & Concepts
MedicineRheumatoid arthritisTaperingInternal medicinePopulationClinical endpointArthritisSurgeryRandomized controlled trialComputer scienceEnvironmental healthComputer graphics (images)Rheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsBiosimilars and Bioanalytical Methods